Maha Assi, MD
Infectious Disease · Wichita, KSNPI 1922071224
Payments from drug & device makers
Across 279 payments — averaging $732.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ADMA Biomanufacturing LLC$151K
- Octapharma USA, Inc.$25K
- Mannkind Corporation$13K
- Ferring Pharmaceuticals AS$8K
- AbbVie$4K
- Ferring Pharmaceuticals Inc.$2K
- plus $2K from 20 others
Across 184 payments — averaging $923.99 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- ADMA Biomanufacturing LLC$170K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ADMA Biomanufacturing LLC | 153 | $150,520 |
| Octapharma USA, Inc. | 4 | $24,583 |
| Mannkind Corporation | 1 | $12,561 |
| Ferring Pharmaceuticals AS | 9 | $8,400 |
| AbbVie(2 entities) | 31 | $4,145 |
| Ferring Pharmaceuticals Inc. | 3 | $2,421 |
| Insmed, Inc. | 25 | $381 |
| Amgen | 2 | $218 |
| Melinta Therapeutics, LLC | 9 | $142 |
| Hospira, Inc. | 8 | $139 |
| Gilead | 7 | $135 |
| Novo Nordisk | 1 | $121 |
| Recor Medical Inc | 1 | $110 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $84 |
| AstraZeneca | 4 | $74 |
| Grifols USA, LLC | 3 | $68 |
| Pfizer | 2 | $51 |
| Merck | 3 | $46 |
| Shionogi Inc | 2 | $40 |
| Astellas Pharma US Inc | 2 | $29 |
| Davol Inc. | 1 | $26 |
| Invivyd Inc | 1 | $22 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| Romark Laboratories, LC | 1 | $22 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $18 |
| Bio Products Laboratory USA, Inc. | 1 | $11 |
How this compares
$204,390 in reported general payments places this provider in the 95th percentile of 56 infectious disease providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other infectious disease in Wichita
- Margaret HaganWichita$109K
- Thomas MooreWichita$37K
- Garret SeilerWichita$2K
- Keck HartmanWichita$2K
- Jerry PeterieWichita$2K
- Shelley JonesWichita$2K
- Lisa CloughKansas City$681K
- Michael DriksOverland Park$161K
- Richard BrownCoffeyville$66K
- Wissam El AtrouniKansas City$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.